Serious complications from youth-onset type 2 diabetes arise by young adulthood

Serious complications from youth-onset type 2 diabetes arise by young adulthood

Serious complications from youth-onset type 2 diabetes arise by young adulthoodFindings from NIH-funded study underscore importance of early, intensive treatmentPeople with type 2 diabetes diagnosed during youth have a high risk of developing complications at early ages and have a greater chance of multiple complications within 15 years after diagnosis. “The original TODAY study showed that youth-onset type 2 diabetes is distinct from adult-onset diabetes – it is both more aggressive and more difficult to control,” said Dr. Barbara Linder, NIDDK project scientist for TODAY. TODAY was the first major comparative effectiveness trial for the treatment of type 2 diabetes in youth. Metformin is the only oral medication approved by the U.S. Food and Drug Administration to treat type 2 diabetes in youth. Participants in TODAY2 were monitored annually for signs of diabetes complications, including heart disease, kidney disease, diabetic foot complications, and to report other health events.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!